BR1100558A - family of modified high affinity antibodies for cancer treatment. - Google Patents

family of modified high affinity antibodies for cancer treatment.

Info

Publication number
BR1100558A
BR1100558A BR1100558A BR1100558A BR1100558A BR 1100558 A BR1100558 A BR 1100558A BR 1100558 A BR1100558 A BR 1100558A BR 1100558 A BR1100558 A BR 1100558A BR 1100558 A BR1100558 A BR 1100558A
Authority
BR
Brazil
Prior art keywords
family
high affinity
cancer treatment
modified high
affinity antibodies
Prior art date
Application number
BR1100558A
Other languages
Portuguese (pt)
Inventor
Peter S Mezes
Brian B Gourlie
Mark W Rickson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100558A priority Critical patent/BR1100558A/en
Publication of BR1100558A publication Critical patent/BR1100558A/en

Links

BR1100558A 1997-05-13 1997-05-13 family of modified high affinity antibodies for cancer treatment. BR1100558A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100558A BR1100558A (en) 1997-05-13 1997-05-13 family of modified high affinity antibodies for cancer treatment.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR1100558A BR1100558A (en) 1997-05-13 1997-05-13 family of modified high affinity antibodies for cancer treatment.

Publications (1)

Publication Number Publication Date
BR1100558A true BR1100558A (en) 2008-05-06

Family

ID=39339603

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100558A BR1100558A (en) 1997-05-13 1997-05-13 family of modified high affinity antibodies for cancer treatment.

Country Status (1)

Country Link
BR (1) BR1100558A (en)

Similar Documents

Publication Publication Date Title
AR004357A1 (en) 1-PHENYL-2-DIMETHYLAMINOMETHYL-CYCLOHEXAN-1-OL COMPOUNDS, AND PREPARATION PROCEDURE FOR SUCH COMPOUNDS.
BR9911781B1 (en) illuminator for photodynamic therapy.
FR12C0004I1 (en)
DK1187632T3 (en) Treatment with anti-ErbB2 antibodies
ZA200110004B (en) Use of antibodies against CD20 for the treatment of the graft versus host disease.
TR199800436A3 (en) The use of primidine derivatives for cancer prevention.
NO972228D0 (en) New tumor suppressor gene, HIC-1
ITBO970563A0 (en) OPERATING MACHINE, AND RELATED PROCEDURE, FOR THE PROCESSING OF FLAT BODIES.
DK0972024T3 (en) Tumor suppressor designed TS10Q23.3
IT1302243B1 (en) SUMMARY OF 1,1,1,3,3-PENTAFLUOROPROPANO.
PT840620E (en) IL-8 ANTAGONISTS FOR ASTHMA TREATMENT
MA24485A1 (en) ATROPISOMERS OF 3-HETEROARYL-4 (3H) -QUINAZO LINONES.
DZ2665A1 (en) Conjugates useful for the treatment of prostate cancer.
TR199800604A3 (en) Anti-fas antibodies.
DE69628458D1 (en) 25-HYDROXY-16-ENE-26.27-BISHOME-CHOLECALCERIFEROL DERIVATIVES
EA200000208A1 (en) IMMOBILIATOR
BR1100558A (en) family of modified high affinity antibodies for cancer treatment.
BR1100582B1 (en) family of modified high affinity antibodies for cancer treatment.
IT242987Y1 (en) FURNITURE FOR FURNITURE.
AR019572A1 (en) ADSORTION PROCEDURE FOR THE DESAROMATIZATION OF HYDROCARBONS.
TR199700863A3 (en) Paclitaxel preparation process.
DE69823022D1 (en) NEW, HUMAN TUMOR SUPPRESSOR.
ES1039966Y (en) LAMP FOR VEHICLES.
BR9703451A (en) Natural compound for treatment of diabetes, cancer and etc.
ES1028845Y (en) SLIDE FOR CHANGES OF VIA FERREA.